ArticleExperimental and therapeutic medicine2015

Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways.

Q I Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.